EconPapers    
Economics at your fingertips  
 

Government R&D Subsidy and Additionality of Biotechnology Firms: The Case of the South Korean Biotechnology Industry

Kwangsoo Shin (), Minkyung Choy (), Chul Lee () and Gunno Park ()
Additional contact information
Kwangsoo Shin: Department of Biomedical Convergence, College of Medicine, Chungbuk National University, 1 Chungdae-ro, Seowin-gu, Cheongju-si 28644, Korea
Minkyung Choy: Management Research Center, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea
Chul Lee: Division of Data Analysis, Korea Institute of Science and Technology Information (KISTI), 66 Hoegi-ro, Dongdaemun-gu, Seoul 02456, Korea
Gunno Park: Technology Innovation Group, SK Telecom, 65 Eulji-ro, Jung-gu, Seoul 04539, Korea

Sustainability, 2019, vol. 11, issue 6, 1-22

Abstract: Government research and development (R&D) subsidies are more important in countries that are latecomers to the biotechnology industry, where venture capital has not been developed, and the ratio of start-ups is high. Previous studies have mostly focused on the additionality of the input and output through government R&D subsidies, such as private R&D investment, technological innovation, and financial performance. In addition, some studies have focused on the behavioral additionality (the change in a firm’s behavior) of firms through government R&D subsidies. However, each study is fragmented and does not provide integrated results and implications. Therefore, this study comprehensively investigated the effects of government R&D subsidies on the multifaceted aspects of input, output, and behavioral additionality based on data from South Korean biotechnology companies. This study used the propensity score matching (PSM) method to prevent selection bias. The results showed that firms benefiting from government R&D subsidies had a markedly higher R&D investment in terms of input additionality, and they produced more technological innovation within a shorter period in terms of output additionality, though financial performance was not determined. Moreover, government R&D subsidies have accelerated strategic alliances and suppressed external financing (debt financing) in terms of behavioral additionality.

Keywords: additionality; biotechnology industry; government R&D subsidies; propensity score matching; South Korea (search for similar items in EconPapers)
JEL-codes: Q Q0 Q2 Q3 Q5 Q56 O13 (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
https://www.mdpi.com/2071-1050/11/6/1583/pdf (application/pdf)
https://www.mdpi.com/2071-1050/11/6/1583/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jsusta:v:11:y:2019:i:6:p:1583-:d:214248

Access Statistics for this article

Sustainability is currently edited by Prof. Dr. Marc A. Rosen

More articles in Sustainability from MDPI, Open Access Journal
Bibliographic data for series maintained by XML Conversion Team ().

 
Page updated 2019-05-10
Handle: RePEc:gam:jsusta:v:11:y:2019:i:6:p:1583-:d:214248